COVID-19 vaccine

Covid-19 EU Seals Deal For Extra 1.8bn BioNTechPfizer Doses

Covid-19: EU Seals Deal For Extra 1.8bn BioNTech/Pfizer Doses

The EU has announced the conclusion of a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of their Covid-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.

Making the announcement, she tweeted from an EU summit in Portugal saying; ‘Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with BioNTech/Pfizer for 2021-2023,

‘Other contracts and other vaccine technologies will follow,’ she further promised.

Read Also: NAFDAC Approves Pfizer-BionTech Vaccine For Emergency Use

The contract, on top of the 600 million BioNTech/Pfizer doses the

Covid-19 Angela Merkel Finally Receives AstraZeneca Jab

Covid-19: Angela Merkel Finally Receives AstraZeneca Jab

German Chancellor Angela Merkel on Friday received her first dose of AstraZeneca’s Covid-19 vaccine, more than two weeks after German authorities recommended the use of the jab only for people aged 60 and over.

Merkel is stepping down this year after nearly 16 years in power.

I am delighted to have received my first vaccination with AstraZeneca today. I thank everyone involved in the vaccination campaign and everyone who gets vaccinated. Vaccination is the key to getting out of the pandemic,’ the 66-year-old said in a tweet posted by her spokesman Steffen Seibert.

In 2019, she sparked concerns for …

South Africa Finds New Variant Of COVID-19, Worse Than Delta

Covid-19: BioNTech Raises Vaccine Output Target To 2.5B Doses

As the world tries to get more people vaccinated against Covid-19, German firm BioNTech on Tuesday announced that it was on track to manufacture 2.5 billion doses of its Covid-19 vaccine this year with US partner Pfizer which was 25 percent more than it originally planned.

According to the pharmaceutical giant, the boost would allow it to ‘address increased demand‘ as countries around the world race to contain new, more contagious virus variants.

The higher output was driven by the recent launch of a new production site in the German city of Marburg, which is now one of …

COVID-19 Over 127,000 Receive Vaccine In Lagos

COVID-19: Over 127,000 Receive Vaccine In Lagos

The Lagos State Ministry of Health has stated that no fewer than 127,885 Lagosians have taken the COVID-19 vaccine, 10 days after the commencement of the exercise.

Commissioner for Health in the State, Prof. Akin Abayomi, who made this disclosure on Sunday after he received reports of day 10 of the exercise from the State Primary Health Care Board, said with the figure, Lagos has vaccinated more people compared to other States of the Federation and FCT.

Going further to explain the demography and categories of persons vaccinated, Abayomi explained that 39,959 health workers, 54,200 essential workers, and 33,726 …

We Are Not in A Haste For Pfizer, BionNTech Vaccine – FGN

As the world is celebrating the success recorded in the manufacturing of COVID-19 vaccine the Federal Government stated Nigeria is not in haste to deploy the use of the latest vaccine the Health Minister reveals.

The pharmaceutical giants Pfizer and German BioNTech announced on Monday that the vaccine is 90 percent effective in preventing people from contracting COVID-19 and this has culminated and this has raised hope around the world with the US President Trump and Joe Biden, the President-elect celebrating the development.

Minister of State for Health, Dr. Adeleke Mamora, while speaking during the briefing of the Presidential Task …

COVID-19 UAE Prime Minister Injected With Trial Vaccine

COVID-19: UAE Prime Minister Injected With Trial Vaccine

The Prime Minister of the United Arab Emirates, Sheikh Mohammed bin Rashid Al Maktoum, on Tuesday, disclosed that he was injected with COVID-19 trial vaccine produced by the UAE medical teams.

Read Also: UAE, Israel Seal First Banking Deal

@HHShkMohd, who shared this on Twitter with a photo of a health worker injecting him, said the teams worked relentlessly to make the vaccine available.

He, however, did not state whether or not the vaccine has been endorsed by the World Health Organisation. He also did not reveal his COVID-19 status.

The PM wrote, ‘While receiving the COVID-19 vaccine today. …

Questions Over Russia Vaccine Study ‘Inconsistencies’ (1)

Questions Over Russia Vaccine Study ‘Inconsistencies’

The Lancet medical journal said Thursday it had asked authors of a study on a potential Russian Covid-19 vaccine for clarifications after their research came under scrutiny.

Russia announced last month that its vaccine, named “Sputnik V” after the Soviet-era satellite that was the first launched into space in 1957, had already received approval.

This raised concerns among Western scientists over a lack of safety data, with some warning that moving too quickly on a vaccine could be dangerous.

Read Also: Mexico Warns Setback In Tests Could Delay COVID-19 Vaccine

Russian researchers published their trial findings last week in the …

UK COVID-19 Variant Hits Spain, Sweden

Mexico Warns Setback In Tests Could Delay COVID-19 Vaccine

The Latin American roll-out of a potential COVID-19 vaccine made by AstraZeneca could be set back after the biotech company announced a pause in tests, the government of Mexico, which is involved in developing the drug alongside Argentina, said Tuesday.

AstraZeneca, which is working on a vaccine in conjunction with Oxford University, said that a volunteer had developed an undiagnosed illness and that, in line with security protocols, it was delaying further tests until an independent panel had studied the case.

Pausing vaccine trials “is not an unusual occurrence… and as a consequence the vaccine’s arrival may be delayed” across …

Osinbajo wants equal distribution of COVID-19 vaccine (1)

Osinbajo Wants Equal Distribution Of COVID-19 Vaccine

Vice-President Yemi Osinbajo said the deployment of the COVID-19 vaccine should be done in an equitable and affordable manner rather than on the basis of the highest bidder.

This is in accordance to a statement released by his spokesman, Laolu Akande, at the virtual 2020 EURAFRICA Forum with the theme, “Towards a Realistic Euro-African Partnership During and Beyond the COVID-19 Era”.

Osinbajo said that such an approach would effectively contain the global spread of COVID-19.

The summit featured presentations from notable global leaders, including the UN Secretary-General, Mr Antonio Guterres and …

First Volunteer Receives Italian Anti-COVID-19 Vaccine

First Volunteer Receives Italian Anti-COVID-19 Vaccine

An Italian hospital said on Monday it had inoculated a first volunteer with an anti-COVID-19 vaccine as part of human trials expected to last six months.

The woman, in her 50s, received the first dose developed by Rome-based biotech company ReiThera at the capital’s Spallanzani Institute for infectious diseases.

The trials, developed between ReiThera and Spallanzani researchers, will be carried out on 90 volunteers divided into groups by age to test the efficacy of different dosages of the vaccine, developed since March.

If the first results of Phase 1 of the human trials prove positive, researchers say they will be …

First Volunteer Receives Italian Anti-COVID-19 Vaccine

Germany Doubts Safety Of Russia’s COVID-19 Vaccine

German Health Minister Jens Spahn on Wednesday said Russia’s COVID-19 vaccine had not been sufficiently tested, adding the aim was to have a safe product rather than just being first to start vaccinating people.

The skepticism was promptly debunked by Russia’s health minister Mikhail Murashko, who insisted the vaccine is safe.

President Vladimir Putin announced on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing.

Moscow’s decision to grant approval before final trials have been completed has raised concerns among some experts.

South Africa Begins Human Trial Of COVID-19 Vaccine

South Africa Begins Human Trial Of COVID-19 Vaccine

South Africa began on Wednesday human trials for a potential COVID-19 vaccine as cases continue to rise and concerns grow over potential access to life-saving treatments.

The trial, conducted by Oxford University with local partner University of the Witwatersrand, will consist of 2,000 volunteers from 18 to 65 years of age.

The volunteers will also include some HIV positive patients.

They will be monitored for 12 months after vaccination to asses how well the vaccine guards against COVID-19.

“Once 60% of the population, especially the adult population, becomes immune, …